Definitive Healthcare Corp. DH
Computer Software: Prepackaged Software · IPO 2021 · data as of November 13, 2026
Definitive Healthcare Corp. (DH) is a technology company listed in the US with a market value of about $191M. In the twelve months to September 30, 2026 it had revenue of $227M and net income of -$157M, a net margin of -69.2%.
Its overall Stock Analiz score is 1.6 out of 5 (weak). The strongest part is future growth (3/5); the weakest is shareholder returns (0/5).
Key numbers: a price to free cash flow of 7.9, 5-year revenue growth of 15% a year, a 5-year average ROIC of -28%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 21% below the current price.
About Definitive Healthcare
Definitive Healthcare is listed in the US and classified in computer software: prepackaged software, IPO year 2021. Revenue went from $118M in 2020 to $242M in 2025, growth of about 15.3% a year. It was profitable in 0 of the last 6 years in our data. Its share count rose by 5% over three years (dilution for shareholders). It spends 14% of revenue on research and development.
Score: 1.6 / 5
Checks passed
- P/FCF below 20
- Profit margin improving
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
- 5-year revenue growth above 8% a year
- More cash than debt, or low debt to equity
- Positive free cash flow
- Liabilities below 60% of assets
Checks not passed
- P/E below 25
- P/E below the industry median
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- 5-year EPS growth above 10% a year
- 5-year average ROIC above 12%
Valuation
Growth and quality
Financials, last 6 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $227M | $242M | $252M | $251M | $223M | $166M | $118M |
| Net income | -$157M | -$139M | -$413M | -$202M | -$7M | -$18M | $0 |
| Free cash flow | $24M | $37M | $46M | $38M | $27M | $18M | $22M |
| EPS (diluted) | $-1.51 | $-1.30 | $-3.54 | $-1.79 | $-0.07 | $-0.19 | — |
| Net margin | -69.2% | -57.5% | -163.8% | -80.5% | -3.2% | -10.7% | 0.0% |
| ROIC | — | -38.6% | -77.0% | -21.1% | -1.4% | -1.5% | -1.0% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Is Definitive Healthcare stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 21% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Definitive Healthcare pay a dividend?
Not currently.
Is Definitive Healthcare a good stock to buy?
We do not give buy or sell advice. Definitive Healthcare scores 1.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.